Dwight Earl Heron MD MBA, FACRO, FACR, FCTSI, FASTRO

Breast Cancer, Central Nervous System Cancer, Head & Neck

Enterprise Medical Director, Professor Radiation Oncology, Otolaryngology, Head & Neck Surgery Bon Secours Mercy Health President, American College of Radiation Oncology

Join to View Full Profile

1044 Belmont AvenueYoungstown, OH 44504
Phone+1 330-480-2182

Summary

Dr. Dwight Heron is a Radiation Oncologist based in Youngstown, OH, specializing in breast cancer, central nervous system cancer, and head & neck cancers. He completed his medical education at the University of Rochester School of Medicine and Dentistry in 1995, followed by an internship in internal medicine at NYU Grossman Long Island School of Medicine and a residency in radiation oncology at Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Heron currently serves as the Medical Director at Mercy Health - St. Elizabeth Youngstown Hospital. He has experience in non-melanoma skin cancer, gliomas, positron emission tomography, ultrasonography, and acoustic neuroma. His work has resulted in multiple publications and recent clinical trials focused on various aspects of radiation oncology. Dr. Heron has been recognized as a Fellow of the American Society of Radiation Oncology and has received multiple honors including being listed among Pittsburgh Magazine's City's Best Doctors and as a Regional Top Doctor by Castle Connolly.

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 1996 - 2000
NYU Grossman Long Island School of MedicineInternship, Internal Medicine, 1995 - 1996
University of Rochester School of Medicine and DentistryClass of 1995

Certifications & Licensure

FL State Medical License 2020 - 2027
NY State Medical License 2020 - 2027
CA State Medical License 2020 - 2026
OH State Medical License 2020 - 2026
PA State Medical License 1997 - 2026
WV State Medical License 2023 - 2026
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Fellow American Society of Radiation Oncology (FASTRO) American Society of Radiation Oncology (ASTRO), 2023
City's Best Doctors Pittsburgh Magazine, 2012-2020
Regional Top Doctor Castle Connolly, 2014-2017, 2019
Alpha Omega Alpha (AOA) Honor Society Alpha Omega Alpha, 2013
Best Doctors for Women Pittsburgh Magazine, 2012
Fellow of American College of Radiology (FACR) American College of Radiation Oncology, 2010
Fellow of American College of Radiation Oncology (FACRO) American College of Radiation Oncology, 2009
America's Leading Doctors Black Enterprise, 2008
2005 Exemplary Service Award in Medicine Omega Psi Phi Fraternity, 2005
Teacher of the Year Association of Residents in Radiation Oncology (ARRO), 2001-2002
Join now to see all

Clinical Trials

Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer Start of enrollment: 2004 Oct 01
Completed
Not Applicable
Patient Preference Survey for Radiation Oncologists Start of enrollment: 2006 Apr 01
Completed
Not Applicable
MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2005 Nov 11
Terminated
Phase 1, Phase 2
SBRT + TACE for Primary Hepatocellular Carcinoma Start of enrollment: 2009 Jul 01
Withdrawn
Not Applicable
Hypofractionated SBRT For Prostate Cancer Start of enrollment: 2010 Oct 07
Completed
Not Applicable
Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2007 Dec 26
Completed
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation Start of enrollment: 2013 Jun 07
Terminated
Phase 2
Radiosurgery for Patients Recurrent Oligometastatic Disease Start of enrollment: 2011 Jun 28
Completed
Not Applicable
SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma Start of enrollment: 2013 Feb 06
Completed
Not Applicable
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma Start of enrollment: 2011 Jul 25
Completed
Phase 2
Stereotactic Body Radiation Therapy (SBRT) for Liver Mets Start of enrollment: 2012 Mar 23
COMPLETED
NA
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Fractionated Stereotactic Radiosurgery for Large Brain Metastases Start of enrollment: 2013 Jul 16
COMPLETED
NA
SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN Start of enrollment: 2013 Jul 03
Completed
Phase 2
An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System Start of enrollment: 2011 Apr 01
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Recurrent Squamous Cell Carcinoma of the Head & Neck: Novel Approaches to Re-Irradiation.
Dwight E Heron, Matthew C Ward, Sue S Yom, Carl R Peterson 3rd, Sharon A Spencer
Otolaryngologic Clinics of North America. 2025-09-29
1 citations
Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline.
Debra Nana Yeboa, Steve E Braunstein, Alvin Cabrera, Kevin Crago, Evanthia Galanis
Practical Radiation Oncology. 2025-06-25
General Consensus on Implementing an Episode-Based Payment Model: Results From the American College of Radiation Oncology (ACRO) Payment Reform Survey.
Joseph A Wilding, James S Clifford, Dwight E Heron, Christopher D Jahraus, Jason McKitrick
Cureus. 2025-04-01

Journal Articles

Utilizing Clinical Pathways and Web-Based Conferences to Improve Quality of Care in a Large Integrated Network Using Breast Cancer Radiation Therapy as the Model
Allison E Garda, Dwight E Heron, Scott M Glaser, Katherine S Chen, John A Vargo, Sushil Beriwal, BioMed Central

Other

A Dosimetric Evaluation of the IAEA‐AAPM TRS483 Code of Practice for Dosimetry of Small Static Fields Used in Conventional Linac Beams and Comparison with IAEA TRS‐398...
Dwight Heron, MD, Medical Physics
https://www.doximity.com/articles/486343da-d0ca-49a3-a7ea-1b492ed6ec73
UpToDate, Wolters Kluwer Health - 2012-08-15

Authored Content

A Dosimetric Evaluation of the IAEA‐AAPM TRS483 Code of Practice for Dosimetry of Small Static Fields Used in Conventional Linac Beams and Comparison with IAEA TRS‐398, AAPM TG51 and TG51 Addendum ProtocolsJuly 2018

Press Mentions

Fuse Oncology, ACRO Partner to Integrate Clinical Pathways PlatformMarch 13th, 2025
Progress Report on Radiation TherapyJuly 9th, 2024
Specialized Doctor Brings New Technology to the Valley for Fighting Against CancerFebruary 24th, 2021
Join now to see all

Grant Support

UPMC Mckeesport - Rocog II - Sustained Community Clinical Trial PhaseNational Cancer Institute2009–2010
UPMC Mckeesport/Rocog Radiation Oncology Minorities Outreach GroupNational Cancer Institute2007–2008
UPMC Mckeesport/Rocog Radiation Oncology Minorities Out*National Cancer Institute2003–2007